Daniel W Fitzgerald - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Daniel W Fitzgerald

Showing results (121-130 of 123) with videos related to

Pageof 13

Sort By:

You have reached the last page of results.This site can display upto 123 results.

Contemporary Clinical Trials|September 7, 2025

Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB designEkaterina V Kurbatova, Kelly E Dooley, Wendy Carr, et al.

Lancet Regional Health. Americas|April 9, 2024

Spectrum of prevalent cardiovascular diseases in urban Port-au-Prince, Haiti: a population-based cross-sectional studyLily D Yan, Rodney Sufra, Reichling St Sauveur, et al.

Genome Medicine|October 15, 2025

A human YEATS4 variant confers resistance to TST and IGRA conversion despite Mycobacterium tuberculosis exposureClément Conil, Jonathan Bohlen, Elouise E Kroon, et al.

Pageof 13

Search research articles

Showing results (121-130 of 123) with videos related to

Sort By:

Pageof 13

You have reached the last page of results.This site can display upto 123 results.

Contemporary Clinical Trials|September 7, 2025

Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB designEkaterina V Kurbatova, Kelly E Dooley, Wendy Carr, et al.

Lancet Regional Health. Americas|April 9, 2024

Spectrum of prevalent cardiovascular diseases in urban Port-au-Prince, Haiti: a population-based cross-sectional studyLily D Yan, Rodney Sufra, Reichling St Sauveur, et al.

Genome Medicine|October 15, 2025

A human YEATS4 variant confers resistance to TST and IGRA conversion despite Mycobacterium tuberculosis exposureClément Conil, Jonathan Bohlen, Elouise E Kroon, et al.

Pageof 13